Recorded Chinese product: 诺氟沙星滴眼液诺氟沙星滴眼液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

诺氟沙星是一种在国家药监局注册认定的药品。该药品含有诺氟沙星-0913cfff等成分。

该药品关联的活性成分包括:诺氟沙星Nuofu Shaxing。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:安徽省双科药业有限公司Chinese legal name: 安徽省双科药业有限公司。

您可以探索含有相同成分的其他药品:诺氟沙星-0913cfff成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 诺氟沙星滴眼液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 诺氟沙星Nuofu Shaxing.

Manufacturers recorded for this product: 安徽省双科药业有限公司Chinese legal name: 安徽省双科药业有限公司.

Explore other medicines containing the same ingredient: 诺氟沙星 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 诺氟沙星滴眼液Recorded Chinese product: 诺氟沙星滴眼液
  • 剂型Dosage form: 滴眼剂Eye drops
  • 规格Specification: 8ml:24mg8 mL:24 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 安徽省双科药业有限公司Chinese legal name: 安徽省双科药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20045278

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20045278

Manufacturer

Chinese legal name: 安徽省双科药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20045278

生产企业

安徽省双科药业有限公司(国产)

适应症

本品用于敏感菌所致的外眼感染,如结膜炎、角膜炎、角膜溃疡等。

用法用量

滴入眼睑内,一次1~2滴,一日3~6次。

不良反应

轻微一过性局部刺激,如刺痛、痒、异物感等。

禁忌

对本品及氟喹诺酮类过敏患者禁用。

注意事项

严重肾功能不全患者慎用。

贮藏

遮光,密闭保存。

规格

8ml:24mg

证据Evidence

  • 批准文号: 国药准字H20045278
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.